We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

DRD3 rs6280: Understanding the Ser9Gly Dopamine Receptor Variant

rs6280
Trait
Moderate evidenceGene: DRD3

The rs6280 variant, also known as Ser9Gly, is a functional genetic change located within the DRD3 gene. It is associated with variations in dopamine receptor sensitivity and has been studied for its potential links to reward processing, personality traits, and susceptibility to certain psychiatric or addictive behaviors.

What each genotype means

C/CModerate attention

Serine homozygous genotype

This genotype results in the Serine (Ser) amino acid at position 9 of the DRD3 receptor. Research suggests this variant may be associated with differences in dopamine receptor sensitivity and has been studied for its potential influence on treatment response to certain antipsychotic medications. Please discuss any medication-related concerns with your clinician or pharmacist.

This is a common genotype globally, though frequencies vary significantly by ancestral background.

C/GModerate attention

Serine-Glycine heterozygous genotype

This genotype indicates you carry one copy of the Serine allele and one copy of the Glycine allele at this position. Studies have explored how this variation in the DRD3 receptor might relate to personality traits or susceptibility to certain behavioral conditions, though findings across different populations remain inconsistent. Please discuss any medication-related concerns with your clinician or pharmacist.

This heterozygous state is frequently observed in many populations worldwide.

G/GModerate attention

Glycine homozygous genotype

This genotype results in the Glycine (Gly) amino acid at position 9 of the DRD3 receptor. This variant is often investigated in the context of dopamine-related neurological and psychiatric traits, with some studies suggesting it may influence how individuals respond to specific therapeutic interventions. Please discuss any medication-related concerns with your clinician or pharmacist.

This genotype is common, with the Glycine allele appearing at a high frequency in many global populations.

What is the rs6280 Variant?

The rs6280 variant is a single-nucleotide polymorphism (SNP) located in the DRD3 gene, which encodes the dopamine D3 receptor. This specific variant is often referred to as the Ser9Gly polymorphism because it results in a substitution of the amino acid serine with glycine at position 9 of the protein. Because this change occurs within the coding region of the gene, it is considered a functional missense mutation. This means the alteration can potentially change the structure or stability of the D3 receptor protein, which plays a critical role in how the brain processes dopamine. Dopamine is a neurotransmitter essential for motivation, reward, and motor control. By altering the receptor's function, the rs6280 variant may influence how effectively dopamine signals are transmitted within specific regions of the brain, such as the striatum, which is heavily involved in reward-seeking behavior and habit formation.

The Role of the DRD3 Gene

The DRD3 gene provides instructions for making the dopamine D3 receptor, a protein found primarily in the limbic system of the brain. This area is central to emotional regulation, reward, and cognitive function. Unlike other dopamine receptors that are more widely distributed, the D3 receptor is highly localized, suggesting it has specialized roles in modulating complex behaviors. Research indicates that the D3 receptor acts as a 'fine-tuner' of dopamine signaling. When dopamine binds to these receptors, it helps regulate the intensity of the reward signal. Because the rs6280 variant changes the amino acid sequence of this receptor, scientists have long hypothesized that it could lead to differences in how individuals respond to rewarding stimuli. This has made the gene a primary candidate in studies investigating the biological underpinnings of addiction, mood disorders, and even movement-related conditions, as the receptor's influence extends to the pathways governing motor activity.

Research and Associations

Scientific research into rs6280 has produced a complex and sometimes inconsistent body of evidence. Many studies have explored its association with psychiatric conditions, including alcohol dependence, schizophrenia, and major depressive disorder. For instance, some research has suggested that specific genotypes may be more prevalent in individuals with alcohol dependence, particularly in certain populations. However, other large-scale meta-analyses have found no significant association between this variant and the risk of schizophrenia, highlighting the difficulty of linking a single genetic variant to complex, polygenic psychiatric traits. Furthermore, studies using PET imaging have shown that the variant can influence dopamine release in the striatum during reward-based tasks. It is important to note that these associations are statistical in nature and do not imply a direct cause-and-effect relationship. The influence of rs6280 is likely subtle and interacts with a vast array of other genetic, environmental, and lifestyle factors, making it only one small piece of a much larger biological puzzle.

Interpreting Your Information

If you have access to your genetic data regarding the rs6280 variant, it is essential to view this information within the context of current scientific limitations. Genetic associations are often identified in specific populations, and findings may not generalize across different ancestral backgrounds. Because the evidence linking this variant to specific health outcomes is mixed or moderate, it cannot be used to predict individual behavior or diagnose medical conditions. If you are concerned about how your genetics might influence your response to medications or your susceptibility to certain health conditions, you should consult with a qualified healthcare provider or a genetic counselor. They can help you interpret your results in the context of your personal and family medical history. Never make changes to your medication regimen or health habits based on genetic reports without first discussing them with your clinician or pharmacist, as they are best equipped to provide personalized medical guidance.

How common is this variant?

The rs6280 variant is common globally, with a minor allele frequency (MAF) of approximately 30%. Frequencies can vary significantly depending on ancestral background.

Frequently asked questions

Is rs6280 a diagnostic test for addiction?

No, rs6280 is not a diagnostic test. While some studies suggest statistical associations between this variant and addictive behaviors, it is not a predictive tool for diagnosing any medical or psychiatric condition.

Does the rs6280 variant affect medication response?

Some research suggests that DRD3 variants may influence responses to certain psychiatric medications. If you are concerned about your medication, please discuss your genetic profile and treatment plan with your clinician or pharmacist.

What does 'Ser9Gly' mean?

Ser9Gly refers to the specific change in the protein structure where the amino acid serine (Ser) is replaced by glycine (Gly) at the ninth position of the dopamine D3 receptor protein.

Are the associations with rs6280 consistent across all studies?

No, the findings are often inconsistent. Many studies show conflicting results, which is common in genetic research on complex behavioral traits influenced by many different genes and environmental factors.

Sources & further reading

Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs6280?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29